Non-visit Based Intervention for Lipidemia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Lancaster General Hospital, Lancaster, PA
Lipidemia
Non-visit Based Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This pilot study consists of a pair of pragmatic clinical trials that will evaluate two separate methods for optimizing referral of eligible patients to a centralized pharmacy service for statin management: 1) A stepped wedge clinical trial, with randomization at the level of the provider, evaluating a visit-based nudge for referral to pharmacy services versus usual care; 2) A cluster randomized trial, with randomization at the level of the practice, evaluating a non-visit based nudge for referral to pharmacy services versus usual care.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 1 Secondary · Reporting Duration: 9 months

9 months
LDL Control
Number of Participants Prescribed a Statin (office-visit level)
Number of Participants Prescribed a Statin (population level)
Statin Pharmacy Dispense Rate
Statin Prescription (office-visit level)
Statin Prescription (population level)

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Control
1 of 3
Non-visit Based Intervention
1 of 3
Visit-Based Intervention
1 of 3
Active Control
Experimental Treatment

84 Total Participants · 3 Treatment Groups

Primary Treatment: Non-visit Based Intervention · No Placebo Group · N/A

Non-visit Based Intervention
Behavioral
Experimental Group · 1 Intervention: Non-visit Based Intervention · Intervention Types: Behavioral
Visit-Based Intervention
Behavioral
Experimental Group · 1 Intervention: Visit-Based Intervention · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 9 months
Closest Location: Lancaster General Hospital · Lancaster, PA
2012First Recorded Clinical Trial
0 TrialsResearching Lipidemia
87 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a LGH PCP.
You are 21 to 75 years old.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.